- Home
- MIST vs DAKT Comparison
MIST vs DAKT Comparison
Compare MIST & DAKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- DAKT
- Stock Information
- Founded
- MIST 2003
- DAKT 1968
- Country
- MIST Canada
- DAKT United States
- Employees
- MIST N/A
- DAKT N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- DAKT Office Equipment/Supplies/Services
- Sector
- MIST Health Care
- DAKT Industrials
- Exchange
- MIST Nasdaq
- DAKT Nasdaq
- Market Cap
- MIST 145.3M
- DAKT 710.0M
- IPO Year
- MIST N/A
- DAKT 1994
- Fundamental
- Price
- MIST $1.94
- DAKT $22.73
- Analyst Decision
- MIST Strong Buy
- DAKT Strong Buy
- Analyst Count
- MIST 3
- DAKT 1
- Target Price
- MIST $6.33
- DAKT $26.00
- AVG Volume (30 Days)
- MIST 1.2M
- DAKT 524.1K
- Earning Date
- MIST 11-11-2025
- DAKT 09-10-2025
- Dividend Yield
- MIST N/A
- DAKT N/A
- EPS Growth
- MIST N/A
- DAKT 9.66
- EPS
- MIST N/A
- DAKT 0.23
- Revenue
- MIST N/A
- DAKT $749,361,000.00
- Revenue This Year
- MIST N/A
- DAKT $10.38
- Revenue Next Year
- MIST N/A
- DAKT $6.41
- P/E Ratio
- MIST N/A
- DAKT $97.24
- Revenue Growth
- MIST N/A
- DAKT N/A
- 52 Week Low
- MIST $0.63
- DAKT $10.24
- 52 Week High
- MIST $2.75
- DAKT $24.38
- Technical
- Relative Strength Index (RSI)
- MIST 64.09
- DAKT 73.67
- Support Level
- MIST $1.75
- DAKT $17.15
- Resistance Level
- MIST $2.06
- DAKT $24.38
- Average True Range (ATR)
- MIST 0.09
- DAKT 0.88
- MACD
- MIST 0.02
- DAKT 0.62
- Stochastic Oscillator
- MIST 66.67
- DAKT 77.97
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About DAKT Daktronics Inc.
Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.